|
Market Closed -
Nasdaq
00:00:00 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 74.85 USD | +0.88% |
|
+9.75% | -8.59% |
| Market Cap | 3.28B 2.94B 2.71B 2.45B 4.58B 312B 4.67B 32.27B 12.95B 164B 12.33B 12.06B 517B | P/E 2026 * |
-10.6x | P/E 2027 * | 561x |
|---|---|---|---|---|---|
| Enterprise Value | 2.95B 2.64B 2.43B 2.2B 4.11B 280B 4.19B 28.97B 11.63B 147B 11.06B 10.83B 464B | EV / Sales 2026 * |
4x | EV / Sales 2027 * | 3.05x |
| Free-Float |
97.31% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TARS | Delayed | |
CBOE
| TARS | Real-time |
Last Transcript: Tarsus Pharmaceuticals, Inc.
| 1 day | +0.88% | ||
| 1 week | +9.75% | ||
| 1 month | -4.78% | ||
| 3 months | +26.78% | ||
| 6 months | +17.67% | ||
| Current year | -8.59% |
| 1 week | 68.36 |  | 76.27 |
| 1 month | 67.65 | | 76.64 |
| Current year | 53.89 | | 91.53 |
| 1 year | 53.89 | | 91.53 |
| 3 years | 14.48 | | 91.53 |
| 5 years | 10.8 | | 91.53 |
| 10 years | 10.8 | | 91.53 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 48 | 01/09/2018 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 64 | 24/04/2023 |
| Chief Tech/Sci/R&D Officer | 47 | 04/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CHM | Chairman | 48 | 02/12/2022 |
| Director/Board Member | 71 | 01/12/2019 | |
Bill Link
BRD | Director/Board Member | 80 | 01/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/09/26 | Exercice | Director | 604 | 0.0014% | ||
| 15/09/26 | Exercice | Director | 12,902 | 0.0294% | ||
| 15/09/26 | Exercice | Director | 402 | 0.0009% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.88% | +9.75% | +8.78% | +425.63% | 3.28B | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | |
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| Average | +1.96% | +6.28% | +42.80% | +118.67% | 426.52B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.48% | +100.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 737M 660M 607M 550M 1.03B 69.97B 1.05B 7.24B 2.91B 36.8B 2.77B 2.71B 116B | 920M 824M 758M 687M 1.28B 87.36B 1.31B 9.04B 3.63B 45.95B 3.45B 3.38B 145B |
| Net income | -319M -286M -263M -238M -445M -30.29B -453M -3.13B -1.26B -15.93B -1.2B -1.17B -50.25B | 9.62M 8.61M 7.92M 7.18M 13.42M 913M 13.67M 94.49M 37.93M 480M 36.1M 35.33M 1.52B |
| Net Debt | -336M -301M -277M -251M -469M -31.93B -478M -3.3B -1.33B -16.79B -1.26B -1.24B -52.97B | -476M -426M -392M -355M -664M -45.16B -676M -4.67B -1.88B -23.76B -1.78B -1.75B -74.92B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | $74.85 | +0.88% | 595,209 |
| 29/10/26 | $74.20 | +2.98% | 458,416 |
| 28/10/26 | $72.05 | +1.82% | 400,071 |
| 27/10/26 | $70.76 | +1.04% | 747,960 |
| 26/10/26 | $70.03 | +2.68% | 877,126 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
Select your edition
All financial news and data tailored to specific country editions
